glp 1 agonist therapy GLP-1 receptor agonists glp 1 signaling GLP-1R agonist

Why Obesity Prevalence Alone is not an Accurate Driver for GLP-1 Sales Segmental Analysis The market is segmented by molecule class, route of administration, payer type, use-case framing, and region

de Levia, Brugus, de Leiva-Prez

The situation becomes more concerning for diabetic patients using these medications, as their risk of intestinal obstruction jumps 4.5 times higher compared to those using other glucose control options

Pharma-cise in the glucagon-like peptide-1 receptor agonists era: a concept whose time has come

Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same

For example, a recent study indicated that unlike in mouse islets where tirzepatide stimulates insulin secretion predominantly through the GLP-1R, the therapeutic effects of tirzepatide on human beta and alpha cells require engagement of both the GLP-1R and the GIPR, and in addition, tirzepatide increased glucagon secretion in isolated islets [207]